Ribomed's innovative technology has been recognized by the leading market research firm, Frost & Sullivan, with its award to Ribomed of the Biological Detection Technologies Excellence in Research of the Year Award for 2005.
Ribomed Recognized by Frost & Sullivan for Excellence in Biological Detection Technologies Research Naples, Fla. — May 25, 2005 — Frost & Sullivan will present Ribomed Biotechnologies, Inc. with the 2005 Biological Detection Technologies Excellence in Research of the Year Award at tonight's Excellence in Industrial Technologies Banquet. Ribomed receives the Award for its excellence in research and development (R&D) and for its introduction of the Abscription® process that detects both disease cells and germs that serve as biological warfare agents. Abscription, a contraction of abortive transcription, is a rapid, robust, isothermal, polymerase chain reaction (PCR)-free method for detecting and quantifying target proteins and nucleic acids. It is an integral part of Ribomed's RiboMaker® Detection System. Abscription's development was driven by four major requirements in clinical, and later, biological defense detection systems. The first was the inadequacy of conventional detection systems in terms of time, efficiency, and practicality. The second was the rising cost of healthcare, which created a need to improve diagnosis and drug development. The third factor was the U.S. Government's apprehension about national security from biological attacks both at home and abroad. Lastly, the growth of molecular genetics promotes molecular detection of diseases and the development of disease- and patient- specific drugs. "Abscription uses the reiterative synthesis of short RNA Abscripts®, which are produced by the RiboMaker® Abscriptase® enzyme, to rapidly generate thousands of detectable and quantifiable signals per target per minute," says Frost & Sullivan research analyst Michael Valenti. "Abscripts® are generated from an artificially created start site for Abscription, called an Abscriptase ® Promoter Cassette (APC)." Modular RiboMaker® APCs can be linked to targeted molecules such as RNA, DNA, or protein, and, since Abscription is linear, the amount of Abscripts® generated is directly proportional to the number of target molecules present. Abscripts® can be tagged with reporters, affinity tags, or haptens during the Abscription process by incorporating Ribomed's proprietary tagged Ribonucleotide analogs (RiboLogs®). They are then fed into several different secondary signaling systems, leading to the rapid production of millions of signals per target. Moreover, Abscription is highly conducive to multiplexing, and can create more than 20 APCs, each producing a unique product. By being able to identify infectious agents accurately in real time using the Abscription-based RiboMaker detection tests, physicians can treat patients at their point-of-care, saving 72 hours of culturing to pick an appropriate treatment. "This time saving can be critical in determining whether persons are victims of a biological attack and in devising the most appropriate method of treating them," notes Valenti. "It has also sparked the funding by several agencies of the federal government in bioterrorism applications." The National Institutes of Health (NIH/NCI, NIAID), the U.S. Department of Defense (DARPA), and the Department of Homeland Security (HSARPA) have supported the development of Abscription. "Ribomed continues to exploit the robustness of the Abscription® process by developing a bloodbased test for rapid development of vaccines to deadly viruses and bacteria," observes Valenti. 7550 IH 10 West, Suite 400 San Antonio, TX 78229 Tel. 210.348.1000 Fax 210.348.1003 www.frost.com "The company has a novel approach to identifying both airborne and blood-transmitted pathogens and early disease biomarkers, and has proved its superiority in R&D with its revolutionary technologies for biological detection." Frost & Sullivan presents its Excellence in Research of the Year Award to the company that has carried out new, disruptive research in its industry. The Award recognizes a company's R&D program that Frost & Sullivan expects will bring significant contributions to the industry in terms of adoption, change, and competitive posture. The results of this research may already have altered or will potentially impact certain market sectors. Held in Naples, Fla., the Frost & Sullivan Excellence in Industrial Technologies Awards Banquet honors world-class companies for outstanding performance and achievements in their industries. An annual event, the banquet recognizes the quality and merit of distinguished individuals and companies. About Ribomed Biotechnologies, Inc. Ribomed Biotechnologies, Inc. is a molecular diagnostics company developing rapid, specific and robust tests for the early detection and characterization of diseases and their causative agents, and the screening of drugs for treatment. Ribomed is dedicated to improving the quality of life through early disease detection, noninvasive monitoring and patient- specific therapies. About Frost & Sullivan Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community, by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit www.frost.com. Contact: Stacie Jones 210.247.2450 Stacie.jones @ frost.com http://www.arizonabiotech.com/ http://www.azhttp.com/ http://groups.yahoo.com/group/biotech-news/ ------------------------ Yahoo! Groups Sponsor --------------------~--> What would our lives be like without music, dance, and theater? Donate or volunteer in the arts today at Network for Good! http://us.click.yahoo.com/TzSHvD/SOnJAA/79vVAA/H4xqlB/TM --------------------------------------------------------------------~-> http://www.arizonabiotech.com/ <a href="http://www.arizonabiotech.com/";>Arizona Biotech</a> http://groups.yahoo.com/group/biotech-news/ <a href="http://groups.yahoo.com/group/biotech-news/";>Biotech News</a> http://www.arizonaentrepreneurs.com/ <a href="http://www.arizonaentrepreneurs.com/";>Arizona Entrepreneurs</a> http://www.azhttp.com/ <a href="http://www.azhttp.com/";>Arizona High Tech</a> Yahoo! Groups Links <*> To visit your group on the web, go to: http://groups.yahoo.com/group/biotech-news/ <*> To unsubscribe from this group, send an email to: [EMAIL PROTECTED] <*> Your use of Yahoo! Groups is subject to: http://docs.yahoo.com/info/terms/
